GLP-1 therapy may be appropriate for adults with: Treatment decisions should always be individualized after reviewing medical history, laboratory data, current medications, and overall health goals
402.559.9500 to learn more and find a specialist with the Bariatrics team.
In litigation filed in early 2026, a major GLP-1 manufacturer alleged that testing of compounded injectable semaglutide products found impurity levels as high as 86%, with compounded oral formulations containing impurities as high as 75%
Opened bacteriostatic water should be discarded after 28 days from first puncture
For this reason, some GLP-1 manufacturers recommend using non-oral contraception for four weeks after starting or increasing tirzepatide to reduce the risk of unintended pregnancy
Up to 13 uses per calendar year with an annual maximum of $8,180